Coronavirus (Covid 19) Notice: For what you need to do, please read the latest Government information.
IVF Select is an innovative, approach to assisted reproduction that involves
- Freezing all embryos in an IVF cycle,
- Testing of embryos for unbalanced chromosomes
- Transferring after thawing one at a time in later non-stimulated cycles.
Embryos with abnormal numbers of chromosomes or parts of chromosomes rarely develop into a pregnancy and healthy baby. These are the most frequent causes of IVF failure and miscarriage, especially in older patients. This technique maximises cumulative live birth rates per IVF attempt and minimises multiple pregnancies, which increases the health risks for both mother and baby.
The London Women's Clinic team at London Bridge is one of only a handful of clinics around the world who have pioneered this treatment. The resulting outstanding pregnancy rates, across a wide range of maternal ages, mean you can maximise your chance of a healthy baby.
Benefits of IVF Select
- Only genetically balanced (normal) embryos are transferred
- Pregnancy rates up to 92%
- The risk of multiple pregnancies is lower, which is safer for mother and baby
- The chances of pregnancy loss and miscarriage fall
- It can take less time to become pregnant, rather than standard IVF
- You can store additional embryos for the future
- An affordable and inclusive package, including up to two frozen embryo transfer cycles
How does IVF Select work?
IVF Select incorporates many of the latest innovations in IVF to maximise the chances of a successful and safe single pregnancy:
- Ovarian stimulation individually tailored to optimise the number of mature eggs collected in a single IVF treatment cycle
- Embryos are cultured to the blastocyst stage and monitored by time-lapse imaging
- Unlimited embryo testing for genetic imbalances (aneuploidy and structural abnormalities) by 'Next Generation Sequencing' (NGS) chromosome copy number analysis
- No embryo transfer in the fresh cycle to avoid ovarian hyperstimulation syndrome (OHSS) and improve the chance of pregnancy
- All blastocysts are vitrified (frozen) with a series of transfers of single genetically balanced blastocysts
Meet the IVF Select team
Our dedicated team has over 25 years experience in fertility and genetics
Mr Michel Summers, Consultant in Reproductive Medicine
A graduate of King’s College, Cambridge Mr Summers completed his medical training at the University of Pennsylvania School of Medicine followed by a Clinical Fellowship in Reproductive Endocrinology and Infertility at the Brigham and Women’s Hospital, Harvard Medical School. He is certified by both the American College of Obstetrics and Gynaecology (ACOG) as well as on the GMC Specialist Register as a Consultant in Reproductive Medicine. His special interests include IVF, embryo culture, embryo implantation and preimplantation genetic diagnostics, areas of research in which he has published extensively.
Professor Alan Handyside, Consultant in Pre-implantation Genetics
Professor Handyside is a leading scientist in human embryology and the genetics of early human development having pioneered the development of Preimplantation Genetic Diagnosis (PGD) and Genetic Embryo Testing for chromosome aneuploidy - two groundbreaking techniques for identifying genetic abnormality and for assisting embryo selection. He supports team in all aspects of patient care and continues to lead important developments in embryo assessment.
Dr Julija Gorodeckaja, Fertility and IVF Specialist
Dr Gorodeckaja trained in obstetrics and gynaecology at the Vilnius University Hospital in Lithuania. Since moving to the UK in 2012, she has worked at the Whittington Hospital as a specialist trainee, at the Baltic Medical Centre and at the Kings College Hospital as a clinical fellow. Her specialist interests are in preimplantation genetics (PGS), advanced gynaecological scanning and early pregnancy diagnostics.
Jinjun Wang, Laboratory Manager and Senior Embryologist
Jinjun received his embryology training from the Shenzhen Hospital of Beijing University and Sydney. He has been a member of the team at LWC since 2008 and became Laboratory Manager in 2013. His objective is to maintain the high success rate of the laboratory and introduce new technologies - such as oocyte vitrification and blastomere biopsy - for the benefit of LWC patients.
Elena Linara, Senior Embryologist and Quality Lead
Elena has 10 years’ experience within embryology and is qualified in biomedical sciences, prenatal genetics and fetal medicine, and clinical embryology. She is particularly interested in ocyte and embryo vitrification, prenatal genetics, quality management, intrauterine insemination and egg sharing. Before joining the team at LWC she worked as an embryologist, andrologist and a deputy sperm bank manager.